Tetrahydroisoquinolinylmethylbenzamide compounds
US-2026049060-A1 · Feb 19, 2026 · US
Aralkyl radicals
Aralkyl radicals · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D217/18 |
| Official title | Aralkyl radicals |
| Display label | Aralkyl radicals |
| Total patents | 38 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 11 |
| 2020 | 2 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Treatment of pharmacoresistant epilepsy
US-2025186408-A1 · Jun 12, 2025 · US
Arylamine Compound and Use thereof, Electroluminescent Device and Display Apparatus
US-2025092007-A1 · Mar 20, 2025 · US
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
US-12077488-B2 · Sep 3, 2024 · US
Methods to sensitize tumors to treatment by immunotherapy
US-2023390277-A1 · Dec 7, 2023 · US
Use of strobilurin type compounds for combating phytopathogenic fungi containing an amino acid substitution f129l in the mitochondrial cytochrome b protein conferring resistance to qo inhibitors viii
US-2023357152-A1 · Nov 9, 2023 · US
Compounds Useful for Treating a Mannheimia Haemolytica or Histophilus Somni Infection
US-2022041547-A1 · Feb 10, 2022 · US
Sphinogosine-1 -phosphate receptor modulators for treatment of cardiopulmonary disorders
US-11034691-B2 · Jun 15, 2021 · US
Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection
US-11034650-B2 · Jun 15, 2021 · US
Derivatives of papaverine that are effective hypoxic tumor radiosensitizers
US-2021163453-A1 · Jun 3, 2021 · US
3′ end caps for RNAi agents for use in RNA interference
US-11008570-B2 · May 18, 2021 · US
Condensed cyclic compound and organic light-emitting device including the same
US-10998503-B2 · May 4, 2021 · US
Benzylisoquinoline Alkaloid (BIA) Precursor Producing Microbes, and Methods of Making and Using the Same
US-2021017524-A1 · Jan 21, 2021 · US
Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same
US-10752903-B2 · Aug 25, 2020 · US
Versatile ligand for palladium-catalyzed meta-C—H functionalizations of aromatic substrates
US-10696635-B2 · Jun 30, 2020 · US
Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same
US-10519453-B2 · Dec 31, 2019 · US
3'END CAPS FOR RNAi AGENTS FOR USE IN RNA INTERFERENCE
US-2019390196-A1 · Dec 26, 2019 · US
Compounds Useful for Treating a Mannheimia Haemolytica or Histophilus Somni Infection
US-2019352256-A1 · Nov 21, 2019 · US
Sphinogosine-1-phosphate receptor modulators for treatment of cardiopulmonary disorders
US-2019300527-A1 · Oct 3, 2019 · US
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
US-10385024-B2 · Aug 20, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D217/18?
- CPC C07D217/18 is the Cooperative Patent Classification code for “Aralkyl radicals.”
- How many patents are filed under CPC C07D217/18 (Aralkyl radicals)?
- Our database includes 38 publications tagged with this CPC code.
- Is patent activity under CPC C07D217/18 growing?
- Publication counts under this code: 1 in 2024 vs 2 in 2025 (latest complete years).